Atlas Trials

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Clinical trial NCT05103644 · UNKNOWN

Trial details

NCT number
NCT05103644
Sponsor
Beni-Suef University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-10-30
Primary completion
2023-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.